BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
10 auth. J. Findlay, K. Hopkins, Richard Loy, M. Doumith, D. Meunier, R. Hill, ... R. Pike, N. Mustafa, D. Livermore, N. Woodford
6 2017
6
🐜
🐜 NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases.
10 auth. Anu Jain, K. Hopkins, J. Turton, M. Doumith, R. Hill, Richard Loy, ... D. Meunier, R. Pike, D. Livermore, N. Woodford
6 2014
6
🐜
🐬 In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase.
N. Woodford, R. Pike, D. Meunier, Richard Loy, R. Hill, K. Hopkins
6 2014
6
🐬
🐜 Association of Novel Nonsynonymous Single Nucleotide Polymorphisms in ampD with Cephalosporin Resistance and Phylogenetic Variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae Isolates That Are Highly Resistant to Carbapenems
10 auth. Baharak Babouee Flury, M. Ellington, K. Hopkins, J. Turton, M. Doumith, Richard Loy, ... P. Staves, V. Hinić, R. Frei, N. Woodford
5 2016
5
🐜
🐬 Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.
D. Ironmonger, O. Edeghere, A. Bains, Richard Loy, N. Woodford, P. Hawkey
5 2015
5
🐬
🐜 KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region.
11 auth. J. Findlay, K. Hopkins, M. Doumith, D. Meunier, C. Wiuff, R. Hill, ... R. Pike, Richard Loy, N. Mustafa, D. Livermore, N. Woodford
4 2016
4
🐜
🦁 Development of a pathogen profiling approach for detecting and dissecting markers of pathogenicity and hyper-variability in group B streptococci
Richard Loy
0 2013
0
🦁